United Community Banks Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Jan 9, 2026, 9:46 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The projected increase in earnings and revenue indicates strong financial health, akin to previous earnings reports that positively influenced stock prices.
AI summary
What happened, with direct paths to the underlying reporting
UCB reports Q4 earnings on Jan. 14, 2025, estimated at 71 cents per share. Projected revenue is $273.6 million, up from $251.93 million last year. UCB authorized a $100 million stock repurchase plan on Dec. 8. Shares rose 2.3% recently, closing at $33.28. Analyst ratings show mixed sentiments around price targets.
UCB reports Q4 earnings on Jan. 14, 2025, estimated at 71 cents per share.
Projected revenue is $273.6 million, up from $251.93 million last year.
UCB authorized a $100 million stock repurchase plan on Dec. 8.
Shares rose 2.3% recently, closing at $33.28.
Analyst ratings show mixed sentiments around price targets.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
UCB boosted its 2026 earnings outlook, signaling potential profitability gains. However, shares fell more than 8% as investors focused on weaker-than-expected Bimzelx sales and qu…
UCB's Q4 earnings met consensus estimates at 71 cents per share. Quarterly sales of $278.388 million exceeded expectations of $273.533 million. Net interest margin expanded by 36…
UCB and Biogen reported positive Phase 3 trial results for lupus treatment. The trial met primary and secondary endpoints, indicating significant efficacy. UCB will start a second…